MT-ND5 Gene Leigh Syndrome Genetic Test
Are you concerned about Leigh syndrome due to mitochondrial complex I deficiency? DNA Labs UAE offers the MT-ND5 Gene Leigh syndrome genetic test to provide you with valuable insights into this genetic disorder. Read on to learn more about this test.
Test Details
The MT-ND5 gene Leigh syndrome is a severe neurological disorder caused by mutations in the MT-ND5 gene, which is part of the mitochondrial DNA. This gene plays a crucial role in the energy production process in cells by providing instructions for making a protein that is a subunit of complex I. Leigh syndrome typically manifests in infancy or early childhood and is characterized by progressive loss of mental and movement abilities, muscle weakness, poor coordination, seizures, and respiratory problems. Symptoms can vary but generally worsen over time and can be life-threatening.
Test Components and Price
- Test Name: MT-ND5 Gene Leigh syndrome due to mitochondrial complex I deficiency Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
Sample Condition and Report Delivery
You can provide a blood sample, extracted DNA, or one drop of blood on an FTA Card for this test. The report will be delivered to you within 3 to 4 weeks.
Test Type and Doctor
The MT-ND5 Gene Leigh syndrome genetic test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.
Test Department
This test is conducted in the Genetics department of DNA Labs UAE.
Pre Test Information
Before undergoing the MT-ND5 Gene Leigh syndrome genetic test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MT-ND5 Gene Leigh syndrome due to mitochondrial complex I deficiency.
About NGS Technology
NGS (Next-Generation Sequencing) is a state-of-the-art DNA sequencing technology that allows for the simultaneous analysis of multiple genes. This comprehensive approach provides a detailed view of an individual’s genetic makeup. In the context of Leigh syndrome due to mitochondrial complex I deficiency, NGS genetic testing can identify mutations in the MT-ND5 gene or other genes associated with mitochondrial complex I deficiency.
The Testing Process
The MT-ND5 Gene Leigh syndrome genetic test involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the MT-ND5 gene or other relevant genes. The test results can confirm a diagnosis of Leigh syndrome and provide information about the specific genetic mutation involved.
Benefits of Genetic Testing
Genetic testing can be instrumental in diagnosing Leigh syndrome and assessing the risk of passing on the condition to future generations. It can also aid in treatment decisions, provide insights into prognosis, and identify potential complications. However, it is important to note that genetic testing cannot cure Leigh syndrome or reverse its symptoms. Treatment typically focuses on symptom management and supportive care.
If you suspect Leigh syndrome due to mitochondrial complex I deficiency, the MT-ND5 Gene Leigh syndrome genetic test can provide you with valuable information. Contact DNA Labs UAE today to schedule your test.
| Test Name | MT-ND5 Gene Leigh syndrome due to mitochondrial complex I deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MT-ND5 Gene Leigh syndrome due to mitochondrial complex I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ND5 Gene Leigh syndrome due to mitochondrial complex I deficiency |
| Test Details | MT-ND5 gene Leigh syndrome is a genetic disorder caused by mutations in the MT-ND5 gene, which is a part of the mitochondrial DNA. This gene provides instructions for making a protein that is a subunit of complex I, which is involved in the energy production process in cells. Leigh syndrome is a severe neurological disorder that typically begins in infancy or early childhood. It is characterized by progressive loss of mental and movement abilities, muscle weakness, poor coordination, seizures, and respiratory problems. The symptoms of Leigh syndrome can vary widely, but they generally worsen over time and can be life-threatening. NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that can analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. In the context of Leigh syndrome due to mitochondrial complex I deficiency, NGS genetic testing can be used to identify mutations in the MT-ND5 gene or other genes associated with mitochondrial complex I deficiency. The NGS genetic test for Leigh syndrome due to mitochondrial complex I deficiency typically involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the MT-ND5 gene or other relevant genes. The results of the test can help confirm a diagnosis of Leigh syndrome and provide information about the specific genetic mutation involved. Genetic testing can be useful in diagnosing Leigh syndrome and determining the risk of passing on the condition to future generations. It can also help guide treatment decisions and provide information about prognosis and potential complications. However, it is important to note that genetic testing cannot cure Leigh syndrome or reverse its symptoms. Treatment for Leigh syndrome is generally focused on managing symptoms and providing supportive care. |
